About Ivy Life Sciences
Immune cell experts, dedicated to the development and application of immune cell therapy related technologies.
Your Cell Experts, Ivy Life Sciences
More than 20 years of clinical research on cell therapy.
Ivy Life Sciences is a pioneer in the treatment of liver cancer and lung using immune cell therapy in clinical trials. Immune Killer Cell therapy (IKC) is a patented Ivy technology with international certifications from the United States, China and the Republic of China.
The short-term goal of Ivy Life Sciences focuses on the research and development of immune cells, adult peripheral white blood cells and umbilical cord mesenchymal stem cells (MSC) culture and storage technologies with emphasis on the promotion of clinical trials, and industrialization of alternative therapy. The long-term goal is to combine these technologies to provide cell therapy services such as the treatment of various diseases and anti-aging. With virtually unlimited potential, Ivy Life Sciences is ready for the future, establishing cell banking centers to store existing healthy cells in cryopreservation.
Patents
Immune Killer Cells (IKC®) technology with international patents
USTPO
US9222072
Republic of China
No. 1403581
People's Republic of China
No. 1640566
Clinical Trials
Ivy's past Clinical Trials
-
ClinicalTrials.gov Identifier NCT03515252:
Phase I Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer -
Clinical trial certification NCT03592706: Phase II/III Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy
-
Clinical trial certification NCT03499834: Phase II A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target Therapy
®
GTPLabs
12 Major Features
-
In compliance with international GTP specification and operating environment
-
Class 1,000 cleanrooms with multiple cell operation labs
-
High-efficiency particulate air (HEPA) (filtering 99.99% of particulates)
-
Class 10,000 preparation and changing room standard of the US Federal 209E
-
Single direction movement between rooms, with containment barrier
-
The cell incubator is equipped with a real-time monitoring system for temperature and carbon dioxide concentration
-
Biosafety Cabinet (BSC) can only operate one customers' sample at a time
-
Fully meets all requirement for various cell therapies
-
24-hour real-time monitoring system
-
High-specification laboratory controls for temperature, humidity and pressure
-
Alarm system to monitor abnormal data
-
Response team on standby for troubleshooting
"Cell Processing Center License"
"Cell Processing Center" License"
-
1st in Taiwan to obtain "Cell Processing Center" License" issued by the Ministry of Health and Welfare
Back to top